Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Regulatory News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
71.50    1.50 (2.14%)
Bid:
71.00
Ask:
72.00
Spread: 1.00 (1.408%)
Market Cap: £325.40m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Final Results

12 Dec 2008 12:06

RNS Number : 0481K
Avacta Group PLC
12 December 2008
 



Avacta Group plc

Audited Results for the year to 31 July 2008

On 4 November 2008, Avacta Group plc ("Avacta", the "Group" or the "Company") announced its preliminary results for the year to 31 July 2008. The preliminary results included intangible assets of £7,144,000 and an other reserve of £1,834,000 reflecting the application of reverse acquisition accounting of the transaction whereby Avacta Limited reversed into Avacta Group plc (formerly Readybuy plc) during August 2006. Upon conversion from accounting under United Kingdom Generally Accepted Accounting Practice to International Financial Reporting Standards as adopted by the European Union, it is possible to recognise a different treatment of this transaction within the financial statements, which the Directors believe to be beneficial.

There is no impact on the income statement or the cash flows of the Group in either the current or comparative accounting period

Accordingly, the consolidated balance sheet of the Group has been adjusted from that included within the Preliminary Announcement to reflect this revised treatment resulting in goodwill of £3,563,000 that had been previously recognised within the intangible assets of £7,144,000 now being recognised within the other reserveThe adjusted consolidated balance sheet is included within this announcement. 

There are no other changes to the Preliminary Announcement.

The Company's full Annual Report & Accounts are available on its website at www.avacta.com

Enquiries:

Avacta Group plc

087 0835 4367

Alastair Smith, Chief Executive Officer

Tim Sykes, Chief Financial Officer

Daniel Stewart & Company plc

020 7776 6550

Lindsay Mair / Charlotte Stranner

Novum Securities Limited

020 7562 4700

Henry Turcan

Haggie Financial LLP

020 7417 8989

Nicholas Nelson / Kathy Boate

   

   Consolidated Balance Sheet as at 31 July 2008

2008

2007

£000

£000

Non-current assets

Property, plant & equipment

290

148

Intangible assets

3,581

-

-------------

------------

3,871

148

-------------

------------

Current assets

Trade and other receivables

92

170

Income taxes

84

-

Cash and cash equivalents

1,097

2,527

-------------

------------

1,273

2,697

-------------

------------

Total assets

5,144

2,845

-------------

------------

Current liabilities

Trade and other payables

(234)

(164)

Finance lease obligations

(11)

(11)

-------------

------------

(245)

(175)

-------------

------------

Non-current liabilities

Finance lease obligations

(30)

(41)

-------------

------------

(30)

(41)

-------------

------------

Total liabilities

(275)

(216)

-------------

------------

Net assets

4,869

2,629

-------------

------------

Equity attributable to equity holders of the Company

Called up share capital

900

856

Share premium account

6,524

4,882

Other reserve

(1,729)

(1,729)

Capital reserve

1,899

-

Retained earnings

(2,725)

(1,380)

-------------

------------

Total equity

4,869

2,629

-------------

------------

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR EAAAAFEDPFFE
Date   Source Headline
7th Aug 20097:00 amPRNPre-Close Trading Statement
28th Jul 20095:07 pmRNSHolding(s) in Company
13th Jul 20094:40 pmRNSDirector/PDMR Shareholding
10th Jul 20094:17 pmRNSIssue of Equity
9th Jul 20094:29 pmRNSFurther re Acquisition of Theragenetics Limited
23rd Apr 20097:00 amRNSHalf Yearly Report
23rd Apr 20097:00 amPRNOPTIM Product Launch
31st Mar 200912:20 pmPRNAnalyst Presentation
30th Mar 200912:59 pmPRNDirector/PDMR Shareholding
3rd Mar 20091:17 pmRNSCompletion of Acquisition of Curidium Medica plc
2nd Mar 200912:00 pmRNSResult of Court Hearing
12th Feb 20091:23 pmRNSRule 8.1- (Curidium Medica Plc)
11th Feb 20092:09 pmRNSResults of meetings
9th Feb 200912:39 pmRNSResult of EGM
9th Feb 20097:00 amPRNAcquisition
26th Jan 20097:00 amPRNResult of AGM
16th Jan 20097:00 amRNSOffer Update
15th Jan 20099:24 amPRNAcquisition of Theragenetics Limited
9th Jan 200910:12 amRNSAvacta Group plc Acquisition
9th Jan 20097:00 amPRNAcquisition(s)
8th Jan 20092:29 pmRNSDirector/PDMR Shareholding
7th Jan 20097:00 amRNSIssue of Equity
12th Dec 200812:06 pmRNSFinal Results
20th Nov 20084:14 pmRNSDirector/PDMR Shareholding
5th Nov 200812:42 pmRNSIssue of Equity
4th Nov 20087:00 amPRNFinal Results
13th Oct 20087:00 amPRNChange of Adviser
11th Sep 20087:00 amPRNProduct Launch
21st Aug 20087:00 amPRNTrading Statement
14th Aug 200811:03 amPRNProduct Development Partnership
28th Jul 20087:00 amPRNProduct Launch
23rd Jul 20082:54 pmPRNDirector/PDMR Shareholding
14th Apr 20087:00 amPRNHalf-yearly Report
4th Apr 20085:20 pmRNSDirector/PDMR Shareholding
31st Mar 20087:00 amRNSTotal Voting Rights
10th Mar 20083:12 pmRNSIssue of Equity
31st Jan 200811:36 amRNSTotal Voting Rights
7th Jan 200810:50 amPRNRe Agreement
31st Dec 20077:00 amPRNTotal Voting Rights
14th Dec 20073:30 pmPRNAcquisition(s)
14th Dec 20073:05 pmPRNAGM Statement
21st Nov 20077:01 amRNSNotice of AGM
14th Nov 20079:08 amPRNAcquisition
9th Nov 20074:59 pmPRNDirectorate Appointment
25th Sep 20077:00 amPRNFinal Results
3rd Sep 20077:00 amPRNRe Agreement
14th Aug 20073:59 pmRNSAIM Rule 26 Information
13th Aug 20077:00 amPRNRe Agreement
31st Jul 20073:37 pmRNSTotal Voting Rights
26th Jul 20079:53 amPRNIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.